Treatment of chronic Hepatitis B in adults and adolescents (aged 12 years and older with body weight at least 35 kg) with compensated liver disease. It is indicated for: Treatment-naive patients (those who have not been treated before). Treatment-experienced patients with resistance to Lamivudine, Entecavir, or Adefovir.

Dosage and administration

Recommended Dosage: One tablet (25 mg) taken orally once daily. Instructions: 🕒 Take the medication at the same time each day. 🍲 Take with food (taking it with a meal increases absorption). 🚫 Swallow the tablet whole. Do not chew, crush, or split the tablet. Missed Dose: If you miss a dose by less than 18 hours, take it as soon as possible with food. If more than 18 hours have passed, skip the missed dose.

Hypersensitivity to Tenofovir Alafenamide or any excipients of the drug. Children under 12 years of age or weighing less than 35 kg. Breastfeeding (the drug is excreted in human milk). Decompensated cirrhosis (requires strict medical supervision). Caution: Patients co-infected with HIV/HBV (consult your doctor to avoid developing HIV resistance).

HepBest — Tenofovir Alafenamide 25 mg, 30 pcs, Mylan

100% original product

Active ingredient

Tenofovir Alafenamide

Manufacturer

Mylan

Dosage 25 mg

Dosage form Tablets

Tablets per pack 30

HepBest Tablets — Tenofovir Alafenamide 25 mg (30 Tabs) Mylan

Name: HepBest
Brand: Mylan
SKU: PROD-1
Price: 1318 UAH
Availability: InStock

1318₴ ~~1538₴~~ -14%

HepBest is a cutting-edge antiviral medication used for the treatment of chronic Hepatitis B virus (HBV) infection. Active ingredient: Tenofovir Alafenamide (TAF) 25 mg.

Manufacturer: Mylan (India). Produced under license from Gilead Sciences (USA), Hepbest is the generic version of the brand-name drug Vemlidy.

Key Benefits compared to older therapies (TDF):

✅ High Efficacy: Rapidly reduces viral load to undetectable levels.
🛡️ Improved Safety: Significantly safer for kidneys and bone density compared to Tenofovir Disoproxil Fumarate.
💊 Convenience: Once-daily dosing regimen.

Recommended as a first-line treatment by major international liver associations (EASL, AASLD).

Treatment of chronic Hepatitis B in adults and adolescents (aged 12 years and older with body weight at least 35 kg) with compensated liver disease.

It is indicated for:

Treatment-naive patients (those who have not been treated before).
Treatment-experienced patients with resistance to Lamivudine, Entecavir, or Adefovir.

Recommended Dosage: One tablet (25 mg) taken orally once daily.

Instructions:

🕒 Take the medication at the same time each day.
🍲 Take with food (taking it with a meal increases absorption).
🚫 Swallow the tablet whole. Do not chew, crush, or split the tablet.

Missed Dose: If you miss a dose by less than 18 hours, take it as soon as possible with food. If more than 18 hours have passed, skip the missed dose.

Hypersensitivity to Tenofovir Alafenamide or any excipients of the drug.
Children under 12 years of age or weighing less than 35 kg.
Breastfeeding (the drug is excreted in human milk).
Decompensated cirrhosis (requires strict medical supervision).

Caution: Patients co-infected with HIV/HBV (consult your doctor to avoid developing HIV resistance).

HepBest (TAF) demonstrates a superior safety profile compared to TDF based regimens. Side effects are generally mild and transient.

Common side effects (frequency >5%):

Headache.
Dizziness.
Nausea.
Fatigue.

The drug has minimal impact on renal function and bone mineral density.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 29.03.2026